Apr 16, 2026
Canadian MiniMed 780G users will have a new CGM option with the Simplera Sync, a smaller, calibration-free sensor designed for easier diabetes management.
Apr 14, 2026
Niia Essential demonstrated proof of concept, strong performance and accuracy, and zero insulin delivery failures in its first clinical study.
Apr 9, 2026
Modular Medical's two-part tubeless patch design targets "almost-pumpers," with a planned U.S. commercial launch in Q2 2026.
Apr 8, 2026
Gravity-related pressure changes are causing incorrect insulin delivery, posing serious risks of dangerous highs and low glucose levels.
Apr 6, 2026
The MiniMed Fit wear study is testing adhesive performance across body locations as the device moves closer to commercialization.
Apr 2, 2026
The new insulin reduces injections from daily to once-a-week while maintaining effective glucose control demonstrated in phase 3 clinical trials.
Apr 1, 2026
The company plans to file an IDE with the FDA in Q2 2026 following successful trials in Brazil and Australia.
Mar 31, 2026
A new reporting feature for the iLet Bionic Pancreas helps clinicians quickly identify what’s working and where diabetes management can be improved.
Mar 30, 2026
The bill caps insulin costs, forces rebate transparency, and encourages competition to lower prescription prices overall.
